{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:12:18Z","timestamp":1792419138466,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001068","name":"Dana Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016872","name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R35CA232128"],"award-info":[{"award-number":["R35CA232128"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["P01CA203655"],"award-info":[{"award-number":["P01CA203655"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.isci.2025.112567","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:18:15Z","timestamp":1746184695000},"page":"112567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["IMPDH inhibition induces DNA replication stress and ATR sensitivity in Merkel cell carcinoma"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-8672","authenticated-orcid":false,"given":"Julia L.","family":"Schnabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Ananthapadmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satvik","family":"Gurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara M.","family":"Soroko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prafulla C.","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-167X","authenticated-orcid":false,"given":"James A.","family":"DeCaprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112567_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2025.112567_bib2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112567_bib3","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1158\/1078-0432.CCR-18-4159","article-title":"The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy","volume":"25","author":"Knepper","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.112567_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13073-020-00727-4","article-title":"Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma","volume":"12","author":"Starrett","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.isci.2025.112567_bib5","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1128\/JVI.00385-13","article-title":"Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities","volume":"87","author":"Cheng","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.112567_bib6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1818798116","article-title":"Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response","volume":"116","author":"Park","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112567_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006668","article-title":"Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis","volume":"13","author":"Cheng","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112567_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160513","article-title":"Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma","volume":"7","author":"Ananthapadmanabhan","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2025.112567_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jid.2022.07.015","article-title":"Distinct Radiation Responses in Virus-Positive and Virus-Negative Merkel Cell Carcinoma","volume":"143","author":"Ahmed","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.isci.2025.112567_bib10","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1038\/jid.2013.169","article-title":"Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens","volume":"133","author":"Houben","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.isci.2025.112567_bib11","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2025.112567_bib12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2000.18.12.2493","article-title":"Chemotherapy in neuroendocrine\/Merkel cell carcinoma of the skin: case series and review of 204 cases","volume":"18","author":"Tai","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112567_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13555-019-0288-z","article-title":"Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies","volume":"9","author":"Villani","year":"2019","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.isci.2025.112567_bib14","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F","article-title":"Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma","volume":"85","author":"Voog","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2025.112567_bib15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.112567_bib16","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112567_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/bjd\/ljae018","article-title":"Mycophenolate mofetil inhibits Merkel cell carcinoma growth","volume":"190","author":"Garman","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.isci.2025.112567_bib18","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.isci.2025.112567_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091346","article-title":"Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story","volume":"11","author":"Naffouje","year":"2019","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.isci.2025.112567_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cmet.2018.06.005","article-title":"Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2025.112567_bib21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41556-019-0363-9","article-title":"IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma","volume":"21","author":"Kofuji","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.112567_bib22","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1074\/jbc.M801387200","article-title":"Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11","volume":"283","author":"Sun","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.112567_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2017.09.013","article-title":"mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability","volume":"32","author":"Valvezan","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.112567_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological concentrations of purines and pyrimidines","volume":"140","author":"Traut","year":"1994","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.isci.2025.112567_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.112567_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.112567_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112567_bib28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.molcel.2017.05.001","article-title":"Replication Catastrophe: When a Checkpoint Fails because of Exhaustion","volume":"66","author":"Toledo","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.112567_bib29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2013.10.043","article-title":"ATR prohibits replication catastrophe by preventing global exhaustion of RPA","volume":"155","author":"Toledo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112567_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/cddis.2012.181","article-title":"Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation","volume":"3","author":"Fokas","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2025.112567_bib31","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.18632\/oncotarget.2158","article-title":"Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970","volume":"5","author":"Hall","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2025.112567_bib32","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/1535-7163.MCT-18-0010","article-title":"In The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression","volume":"17","author":"Wallez","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2025.112567_bib33","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.3390\/cancers13143415","article-title":"Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?","volume":"13","author":"Goff","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2025.112567_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/v14010058","article-title":"Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome","volume":"14","author":"Ahmed","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2025.112567_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151666","article-title":"Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma","volume":"132","author":"Lee","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.112567_bib36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1101\/gad.10.7.826","article-title":"Tissue-specific inactivation of p53 tumor suppression in the mouse","volume":"10","author":"Bowman","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2025.112567_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc991","article-title":"Inhibiting the p53-MDM2 interaction: an important target for cancer therapy","volume":"3","author":"Chene","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.112567_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1101\/gad.304071.117","article-title":"Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers","volume":"32","author":"Katz","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2025.112567_bib39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.onc.1201459","article-title":"p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding","volume":"15","author":"Midgley","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.112567_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108808","article-title":"MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity","volume":"34","author":"Branigan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112567_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.isci.2025.112567_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.dnarep.2014.04.008","article-title":"DNA-PK phosphorylation of RPA32 Ser4\/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe","volume":"21","author":"Ashley","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.isci.2025.112567_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100017","article-title":"Progress towards a clinically-successful ATR inhibitor for cancer therapy","volume":"2","author":"Barnieh","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.isci.2025.112567_bib44","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/nprot.2015.066","article-title":"A flow cytometry-based method to simplify the analysis and quantification of protein association to chromatin in mammalian cells","volume":"10","author":"Forment","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2025.112567_bib45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4155\/fmc.15.33","article-title":"Drugging ATR: Progress in the Development of Specific Inhibitors for the Treatment of Cancer","volume":"7","author":"Foote","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.isci.2025.112567_bib46","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s11864-023-01118-8","article-title":"The Evolving Treatment Landscape of Merkel Cell Carcinoma","volume":"24","author":"Singh","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.isci.2025.112567_bib47","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/cancers11091346","article-title":"Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story","volume":"11","author":"Naffouje","year":"2019","journal-title":"Cancers"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225008284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:58:01Z","timestamp":1768964281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225008284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589004225008284"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112567","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IMPDH inhibition induces DNA replication stress and ATR sensitivity in Merkel cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112567"}}